Common Contracts
5 similar Registration Rights Agreement contracts by Arix Bioscience PLC, Metagenomi, Inc., Perspectum Group LTD, others
METAGENOMI, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 5th, 2024 • Metagenomi, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is entered into as of January 24, 2024, by and among Metagenomi, Inc., a Delaware corporation (the “Company”), and the investors listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor.”
PERSPECTUM GROUP LTD REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 12th, 2021 • Perspectum Group PLC • Services-medical laboratories • England and Wales
PERSPECTUM GROUP LTD, a company incorporated in England and Wales under company number 13449248 and having its registered office at Gemini One, John Smith Drive, Oxford Business Park South, Oxford, Oxfordshire OX4 2LL (the “Company”);
PERSPECTUM GROUP LTD REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 25th, 2021 • Perspectum Group LTD • Services-medical laboratories • England and Wales
PERSPECTUM GROUP LTD, a company incorporated in England and Wales under company number 13449248 and having its registered office at Gemini One, John Smith Drive, Oxford Business Park South, Oxford, Oxfordshire OX4 2LL (the “Company”);
AUTOLUS THERAPEUTICS PLC REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 6th, 2018 • Arix Bioscience PLC • Biological products, (no disgnostic substances) • England and Wales
DIALOGIC INC. AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT MARCH 22, 2012Registration Rights Agreement • April 2nd, 2012 • Tennenbaum Capital Partners LLC • Services-computer integrated systems design • Delaware
THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the 22nd day of March, 2012, by and among DIALOGIC INC., a Delaware corporation (the “Company”) and the parties listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor.”
